Advertisement
Screener

electroCore, Inc. (ECOR) Proceeds from Operating Activities

2.8 / 5 stars · 68/120 Roast Me

electroCore, Inc. Proceeds from Operating Activities

electroCore, Inc. (ECOR) reported Proceeds from Operating Activities of $50.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ProceedsFromOperatingActivities · last filed 2026-03-19

  • electroCore, Inc. proceeds from operating activities for the quarter ending 2025-03-31 was $48.00K, a 60.66% decline year-over-year.
  • electroCore, Inc. proceeds from operating activities for the quarter ending 2024-12-31 was -$121.90M.
  • electroCore, Inc. proceeds from operating activities for the quarter ending 2024-09-30 was $0.00.
  • electroCore, Inc. proceeds from operating activities for the quarter ending 2024-06-30 was $121.88M.
  • electroCore, Inc. proceeds from operating activities for fiscal 2025 was $50.00K, a 50.00% decline from fiscal 2024.
  • electroCore, Inc. proceeds from operating activities for fiscal 2024 was $100.00K, a 50.00% decline from fiscal 2023.
  • electroCore, Inc. proceeds from operating activities for fiscal 2023 was $200.00K.
Period endProceeds from Operating ActivitiesProceeds from Operating Activities 3 monthProceeds from Operating Activities 6 monthProceeds from Operating Activities 9 monthProceeds from Operating Activities 12 month
2025-12-31$50.00K
10-K · filed 2026-03-19
2025-03-31$48.00K
10-Q · filed 2025-05-07
-$121.85M
derived: sum of 2 quarters · filed 2026-03-19
-$121.85M
derived: sum of 3 quarters · filed 2026-03-19
$26.00K
derived: sum of 4 quarters · filed 2026-03-19
2024-12-31-$121.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$121.90M
derived: sum of 2 quarters · filed 2026-03-19
-$22.00K
derived: sum of 3 quarters · filed 2026-03-19
$100.00K
10-K · filed 2026-03-19
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$121.88M
derived: sum of 2 quarters · filed 2024-11-13
$122.00M
10-Q · filed 2024-11-13
-$88.80M
derived: sum of 4 quarters · filed 2025-05-07
2024-06-30$121.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$122.00M
10-Q · filed 2024-08-07
-$88.80M
derived: sum of 3 quarters · filed 2025-05-07
2024-03-31$122.00K
10-Q · filed 2025-05-07
-$210.68M
derived: sum of 2 quarters · filed 2025-05-07
2023-12-31-$210.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
$200.00K
10-K · filed 2025-03-12
2023-09-30$211.00M
10-Q · filed 2024-11-13
2023-06-30$211.00M
10-Q · filed 2024-08-07
2023-03-31$211.00K
10-Q · filed 2024-05-08
2023-01-10$211.00K
10-Q · filed 2023-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Vivani Medical, Inc. (VANI)United States$0.111B
Streamex Corp. (STEX)United States$0.089B-0.19
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B